Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Cα (PKCα) and PKCη Expression, Thereby Promoting Viral Propagation

1. Moradpour D, Penin F. 2013. Hepatitis C virus proteins: from structure to

function. Curr Top Microbiol Immunol 369:113–142. https://doi.org/10

.1007/978-3-642-27340-7_5.

2. Moradpour D, Penin F, Rice CM. 2007. Replication of hepatitis C virus. Nat

Rev Microbiol 5:453–463. https://doi.org/10.1038/nrmicro1645.

3. Lohmann V. 2013. Hepatitis C virus RNA replication. Curr Top Microbiol

Immunol 369:167–198. https://doi.org/10.1007/978-3-642-27340-7_7.

4. Neufeldt CJ, Cortese M, Acosta EG, Bartenschlager R. 2018. Rewiring cellular networks by members of the Flaviviridae family. Nat Rev Microbiol 16:

125–142. https://doi.org/10.1038/nrmicro.2017.170.

5. Harak C, Lohmann V. 2015. Ultrastructure of the replication sites of positivestrand RNA viruses. Virology 479–480:418–433. https://doi.org/10.1016/j.virol

.2015.02.029.

6. Backes P, Quinkert D, Reiss S, Binder M, Zayas M, Rescher U, Gerke V,

Bartenschlager R, Lohmann V. 2010. Role of annexin A2 in the production

of infectious hepatitis C virus particles. J Virol 84:5775–5789. https://doi

.org/10.1128/JVI.02343-09.

7. Saxena V, Lai CK, Chao TC, Jeng KS, Lai MM. 2012. Annexin A2 is involved

in the formation of hepatitis C virus replication complex on the lipid raft. J

Virol 86:4139–4150. https://doi.org/10.1128/JVI.06327-11.

8. Solbak SMO, Abdurakhmanov E, Vedeler A, Danielson UH. 2017. Characterization of interactions between hepatitis C virus NS5B polymerase,

annexin A2 and RNA—effects on NS5B catalysis and allosteric inhibition.

Virol J 14:236–403. https://doi.org/10.1186/s12985-017-0904-4.

June 2023 Volume 97 Issue 6

9. Rösch K, Kwiatkowski M, Hofmann S, Schöbel A, Grüttner C, Wurlitzer M,

Schlüter H, Herker E. 2016. Quantitative lipid droplet proteome analysis

identifies annexin A3 as a cofactor for HCV particle production. Cell Rep

16:3219–3231. https://doi.org/10.1016/j.celrep.2016.08.052.

10. Gerke V, Moss SE. 2002. Annexins: from structure to function. Physiol Rev

82:331–371. https://doi.org/10.1152/physrev.00030.2001.

11. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, Oers

van MH. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415–1420.

https://doi.org/10.1182/blood.V84.5.1415.bloodjournal8451415.

12. Sawada N. 2013. Tight junction-related human diseases. Pathol Int 63:

1–12. https://doi.org/10.1111/pin.12021.

13. French AD, Fiori JL, Camilli TC, Leotlela PD, O'Connell MP, Frank BP,

Subaran S, Indig FE, Taub DD, Weeraratna AT. 2009. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma

cells. Int J Med Sci 6:93–101. https://doi.org/10.7150/ijms.6.93.

14. Suzuki T, Elias BC, Seth A, Shen L, Turner JR, Giorgianni F, Desiderio D,

Guntaka R, Rao R. 2009. PKC eta regulates occludin phosphorylation and

epithelial tight junction integrity. Proc Natl Acad Sci U S A 106:61–66.

https://doi.org/10.1073/pnas.0802741106.

15. Rao R. 2009. Occludin phosphorylation in regulation of epithelial tight junctions.

Ann N Y Acad Sci 1165:62–68. https://doi.org/10.1111/j.1749-6632.2009.04054.x.

16. Mee CJ, Grove J, Harris HJ, Hu K, Balfe P, McKeating JA. 2008. Effect of cell

polarization on hepatitis C virus entry. J Virol 82:461–470. https://doi.org/

10.1128/JVI.01894-07.

10.1128/jvi.00655-23

15

Downloaded from https://journals.asm.org/journal/jvi on 06 August 2023 by 133.30.169.29.

At 5 days posttransfection, supernatants from the transfected cells were collected and inoculated into Huh7.5 cells to evaluate viral particle formation by measuring the luciferase reporter activity.

In vitro transcription of HCV RNA, electroporation into cells, and reporter analysis. The HCV replicon plasmid pSGR (1b, Con1)-Luc was digested with ScaI and transcribed in vitro by using a MEGAscript

T7 kit (Ambion). Then 10 m g of in vitro-transcribed HCV RNA was electroporated at 270 V and 960 m F by

a GenePulser Xcells pulse generator (Bio-Rad, Hercules, CA) into 4  106 cells treated with BTXpress

buffer (BTX, Holliston, MA). The electroporated cells were seeded into 24-well plates and harvested at

the indicated time points. The luciferase activity was determined in triplicate using a GloMax 96 microplate luminometer (Promega). The luciferase activity at 4 h after electroporation was used for normalization for the transfection efficiency of HCV RNA.

Confocal microscopy. Cells seeded on glass coverslips in 24-well plates were infected or not with

HCVcc J6/JFH1. At 5 days postinoculation, cells were fixed with ice-cold acetone-methanol (1:1) solution

for 20 min at 220°C, stained with the appropriate antibodies, and then stained with Alexa Fluor 488- or

Alexa Fluor 594-conjugated goat anti-mouse IgG (green) and Alexa Fluor 488- or Alexa Fluor 594-conjugated goat anti-rabbit IgG (red). Nuclei were stained with Hoechst 33342. The cells were mounted on

glass slides and observed under a confocal laser scanning microscope (LSM700; Carl Zeiss, Oberkochen,

Germany).

Statistics. Results are expressed as means 6 standard deviations. Statistical significance was determined by Student’s t test for results shown in Fig. 1D, Fig. 2A, C, and D, and Fig. 3B, C, and D and by oneway analysis of variance (ANOVA) for the results shown in Fig. 1C, Fig. 7A and C, and Fig. 8A. P values of

,0.05 and ,0.01 were considered significant.

17. Jensen ON, Houthaeve T, Shevchenko A, Cudmore S, Ashford T, Mann M,

Griffiths G, Krijnse Locker J. 1996. Identification of the major membrane

and core proteins of vaccinia virus by two-dimensional electrophoresis. J

Virol 70:7485–7497. https://doi.org/10.1128/JVI.70.11.7485-7497.1996.

18. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L,

Wang D, Camp DG, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson

JA. 2004. Identification of proteins in human cytomegalovirus (HCMV)

particles: the HCMV proteome. J Virol 78:10960–10966. https://doi.org/10

.1128/JVI.78.20.10960-10966.2004.

19. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Sowder

RC, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD,

Lifson JD, Ott DE, Jr. 2006. Proteomic and biochemical analysis of purified

human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 80:9039–9052. https://doi.org/10.1128/

JVI.01013-06.

20. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J Virol 82:8605–8618. https://

doi.org/10.1128/JVI.00904-08.

21. Zhang C, Xue C, Li Y, Kong Q, Ren X, Li X, Shu D, Bi Y, Cao Y. 2010. Profiling

of cellular proteins in porcine reproductive and respiratory syndrome virus virions by proteomics analysis. Virol J 7:242. https://doi.org/10.1186/

1743-422X-7-242.

22. Berri F, Haffar G, Lê VB, Sadewasser A, Paki K, Lina B, Wolff T, Riteau B.

2014. Annexin V incorporated into influenza virus particles inhibits

gamma interferon signaling and promotes viral replication. J Virol 88:

11215–11228. https://doi.org/10.1128/JVI.01405-14.

23. Sekhar V, Pollicino T, Diaz G, Engle RE, Alayli F, Melis M, Kabat J, Tice A,

Pomerenke A, Altan-Bonnet N, Zamboni F, Lusso P, Emerson SU, Farci P.

2018. Infection with hepatitis C virus depends on TACSTD2, a regulator of

claudin-1 and occludin highly downregulated in hepatocellular carcinoma. PLoS Pathog 14:e1006916. https://doi.org/10.1371/journal.ppat

.1006916.

24. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T. 2009. Tight junction

proteins claudin-1 and occludin control hepatitis C virus entry and are

downregulated during infection to prevent superinfection. J Virol 83:

2011–2014. https://doi.org/10.1128/JVI.01888-08.

25. Baktash Y, Madhav A, Coller KE, Randall G. 2018. Single particle imaging of

polarized hepatoma organoids upon hepatitis C virus infection reveals an

June 2023 Volume 97 Issue 6

Journal of Virology

26.

27.

28.

29.

30.

31.

32.

33.

34.

ordered and sequential entry process. Cell Host Microbe 23:382–394.e5.

https://doi.org/10.1016/j.chom.2018.02.005.

Okamoto T, Omori H, Kaname Y, Abe T, Nishimura Y, Suzuki T, Miyamura T,

Yoshimori T, Moriishi K, Matsuura Y. 2008. A single-amino-acid mutation in

hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication. J Virol 82:3480–3489. https://doi.org/10.1128/JVI.02253-07.

Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R.

1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell

line. Science 285:110–113. https://doi.org/10.1126/science.285.5424.110.

Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC,

Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623–626.

https://doi.org/10.1126/science.1114016.

Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K,

Habermann A, Kräusslich H-G, Mizokami M, Bartenschlager R, Liang TJ. 2005.

Production of infectious hepatitis C virus in tissue culture from a cloned viral

genome. Nat Med 11:791–796. https://doi.org/10.1038/nm1268.

Bungyoku Y, Shoji I, Makine T, Adachi T, Hayashida K, Nagano-Fujii M, Ide

Y-H, Deng L, Hotta H. 2009. Efficient production of infectious hepatitis C

virus with adaptive mutations in cultured hepatoma cells. J Gen Virol 90:

1681–1691. https://doi.org/10.1099/vir.0.010983-0.

Kukihara H, Moriishi K, Taguwa S, Tani H, Abe T, Mori Y, Suzuki T, Fukuhara

T, Taketomi A, Maehara Y, Matsuura Y. 2009. Human VAP-C negatively regulates hepatitis C virus propagation. J Virol 83:7959–7969. https://doi.org/

10.1128/JVI.00889-09.

Bawono RG, Abe T, Shibata Y, Matsui C, Deng L, Shoji I. 2021. NS5A-ISGylation via lysine 26 has a critical role for efficient propagation of hepatitis C

virus genotype 2a. Kobe J Med Sci 67:E38–E47.

Shimizu Y, Shirasago Y, Kondoh M, Suzuki T, Wakita T, Hanada K, Yagi K,

Fukasawa M. 2018. Monoclonal antibodies against occludin completely

prevented hepatitis C virus infection in a mouse model. J Virol 92:e0225817. https://doi.org/10.1128/JVI.02258-17.

Suzuki R, Saito K, Kato T, Shirakura M, Akazawa D, Ishii K, Aizaki H,

Kanegae Y, Matsuura Y, Saito I, Wakita T, Suzuki T. 2012. Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology 432:29–38. https://doi.org/10.1016/j.virol

.2012.05.033.

10.1128/jvi.00655-23

16

Downloaded from https://journals.asm.org/journal/jvi on 06 August 2023 by 133.30.169.29.

HCV Disrupts ANX5-Mediated Occludin Integrity

...